調査レポート | • レポートコード：QYR2104Z5383 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、痙性治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（理学療法、医学治療）、用途別市場規模（子供用、大人用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・痙性治療の市場動向 ・企業の競争状況、市場シェア ・痙性治療の種類別市場規模（理学療法、医学治療） ・痙性治療の用途別市場規模（子供用、大人用） ・痙性治療の北米市場規模2016-2027（アメリカ、カナダ） ・痙性治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・痙性治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・痙性治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・痙性治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Codman & Shurtleff、Medtronic、Sanofi、InMed Pharmaceuticals、Ipsen、Orient Pharma、Taj Pharmaceuticals、MediciNova、Genentech） ・結論 |
Market Analysis and Insights: Global Spasticity Treatment Market
The global Spasticity Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spasticity Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spasticity Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spasticity Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spasticity Treatment market.
Global Spasticity Treatment Scope and Market Size
Spasticity Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Spasticity Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Physical Treatment
Medicine Treatment
Segment by Application
Children
Adults
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Codman & Shurtleff
Medtronic
Sanofi
InMed Pharmaceuticals
Ipsen
Orient Pharma
Taj Pharmaceuticals
MediciNova
Genentech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spasticity Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Physical Treatment
1.2.3 Medicine Treatment
1.3 Market by Application
1.3.1 Global Spasticity Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Spasticity Treatment Market Perspective (2016-2027)
2.2 Spasticity Treatment Growth Trends by Regions
2.2.1 Spasticity Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Spasticity Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Spasticity Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Spasticity Treatment Industry Dynamic
2.3.1 Spasticity Treatment Market Trends
2.3.2 Spasticity Treatment Market Drivers
2.3.3 Spasticity Treatment Market Challenges
2.3.4 Spasticity Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spasticity Treatment Players by Revenue
3.1.1 Global Top Spasticity Treatment Players by Revenue (2016-2021)
3.1.2 Global Spasticity Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Spasticity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Spasticity Treatment Revenue
3.4 Global Spasticity Treatment Market Concentration Ratio
3.4.1 Global Spasticity Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spasticity Treatment Revenue in 2020
3.5 Spasticity Treatment Key Players Head office and Area Served
3.6 Key Players Spasticity Treatment Product Solution and Service
3.7 Date of Enter into Spasticity Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spasticity Treatment Breakdown Data by Type
4.1 Global Spasticity Treatment Historic Market Size by Type (2016-2021)
4.2 Global Spasticity Treatment Forecasted Market Size by Type (2022-2027)
5 Spasticity Treatment Breakdown Data by Application
5.1 Global Spasticity Treatment Historic Market Size by Application (2016-2021)
5.2 Global Spasticity Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Spasticity Treatment Market Size (2016-2027)
6.2 North America Spasticity Treatment Market Size by Type
6.2.1 North America Spasticity Treatment Market Size by Type (2016-2021)
6.2.2 North America Spasticity Treatment Market Size by Type (2022-2027)
6.2.3 North America Spasticity Treatment Market Size by Type (2016-2027)
6.3 North America Spasticity Treatment Market Size by Application
6.3.1 North America Spasticity Treatment Market Size by Application (2016-2021)
6.3.2 North America Spasticity Treatment Market Size by Application (2022-2027)
6.3.3 North America Spasticity Treatment Market Size by Application (2016-2027)
6.4 North America Spasticity Treatment Market Size by Country
6.4.1 North America Spasticity Treatment Market Size by Country (2016-2021)
6.4.2 North America Spasticity Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Spasticity Treatment Market Size (2016-2027)
7.2 Europe Spasticity Treatment Market Size by Type
7.2.1 Europe Spasticity Treatment Market Size by Type (2016-2021)
7.2.2 Europe Spasticity Treatment Market Size by Type (2022-2027)
7.2.3 Europe Spasticity Treatment Market Size by Type (2016-2027)
7.3 Europe Spasticity Treatment Market Size by Application
7.3.1 Europe Spasticity Treatment Market Size by Application (2016-2021)
7.3.2 Europe Spasticity Treatment Market Size by Application (2022-2027)
7.3.3 Europe Spasticity Treatment Market Size by Application (2016-2027)
7.4 Europe Spasticity Treatment Market Size by Country
7.4.1 Europe Spasticity Treatment Market Size by Country (2016-2021)
7.4.2 Europe Spasticity Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Spasticity Treatment Market Size (2016-2027)
8.2 Asia-Pacific Spasticity Treatment Market Size by Type
8.2.1 Asia-Pacific Spasticity Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Spasticity Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Spasticity Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Spasticity Treatment Market Size by Application
8.3.1 Asia-Pacific Spasticity Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Spasticity Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Spasticity Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Spasticity Treatment Market Size by Region
8.4.1 Asia-Pacific Spasticity Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Spasticity Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Spasticity Treatment Market Size (2016-2027)
9.2 Latin America Spasticity Treatment Market Size by Type
9.2.1 Latin America Spasticity Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Spasticity Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Spasticity Treatment Market Size by Type (2016-2027)
9.3 Latin America Spasticity Treatment Market Size by Application
9.3.1 Latin America Spasticity Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Spasticity Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Spasticity Treatment Market Size by Application (2016-2027)
9.4 Latin America Spasticity Treatment Market Size by Country
9.4.1 Latin America Spasticity Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Spasticity Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spasticity Treatment Market Size (2016-2027)
10.2 Middle East & Africa Spasticity Treatment Market Size by Type
10.2.1 Middle East & Africa Spasticity Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Spasticity Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Spasticity Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Spasticity Treatment Market Size by Application
10.3.1 Middle East & Africa Spasticity Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Spasticity Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Spasticity Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Spasticity Treatment Market Size by Country
10.4.1 Middle East & Africa Spasticity Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Spasticity Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Codman & Shurtleff
11.1.1 Codman & Shurtleff Company Details
11.1.2 Codman & Shurtleff Business Overview
11.1.3 Codman & Shurtleff Spasticity Treatment Introduction
11.1.4 Codman & Shurtleff Revenue in Spasticity Treatment Business (2016-2021)
11.1.5 Codman & Shurtleff Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Spasticity Treatment Introduction
11.2.4 Medtronic Revenue in Spasticity Treatment Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Spasticity Treatment Introduction
11.3.4 Sanofi Revenue in Spasticity Treatment Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 InMed Pharmaceuticals
11.4.1 InMed Pharmaceuticals Company Details
11.4.2 InMed Pharmaceuticals Business Overview
11.4.3 InMed Pharmaceuticals Spasticity Treatment Introduction
11.4.4 InMed Pharmaceuticals Revenue in Spasticity Treatment Business (2016-2021)
11.4.5 InMed Pharmaceuticals Recent Development
11.5 Ipsen
11.5.1 Ipsen Company Details
11.5.2 Ipsen Business Overview
11.5.3 Ipsen Spasticity Treatment Introduction
11.5.4 Ipsen Revenue in Spasticity Treatment Business (2016-2021)
11.5.5 Ipsen Recent Development
11.6 Orient Pharma
11.6.1 Orient Pharma Company Details
11.6.2 Orient Pharma Business Overview
11.6.3 Orient Pharma Spasticity Treatment Introduction
11.6.4 Orient Pharma Revenue in Spasticity Treatment Business (2016-2021)
11.6.5 Orient Pharma Recent Development
11.7 Taj Pharmaceuticals
11.7.1 Taj Pharmaceuticals Company Details
11.7.2 Taj Pharmaceuticals Business Overview
11.7.3 Taj Pharmaceuticals Spasticity Treatment Introduction
11.7.4 Taj Pharmaceuticals Revenue in Spasticity Treatment Business (2016-2021)
11.7.5 Taj Pharmaceuticals Recent Development
11.8 MediciNova
11.8.1 MediciNova Company Details
11.8.2 MediciNova Business Overview
11.8.3 MediciNova Spasticity Treatment Introduction
11.8.4 MediciNova Revenue in Spasticity Treatment Business (2016-2021)
11.8.5 MediciNova Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Spasticity Treatment Introduction
11.9.4 Genentech Revenue in Spasticity Treatment Business (2016-2021)
11.9.5 Genentech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Spasticity Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Physical Treatment
Table 3. Key Players of Medicine Treatment
Table 4. Global Spasticity Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Spasticity Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Spasticity Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Spasticity Treatment Market Share by Regions (2016-2021)
Table 8. Global Spasticity Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Spasticity Treatment Market Share by Regions (2022-2027)
Table 10. Spasticity Treatment Market Trends
Table 11. Spasticity Treatment Market Drivers
Table 12. Spasticity Treatment Market Challenges
Table 13. Spasticity Treatment Market Restraints
Table 14. Global Spasticity Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Spasticity Treatment Market Share by Players (2016-2021)
Table 16. Global Top Spasticity Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spasticity Treatment as of 2020)
Table 17. Ranking of Global Top Spasticity Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Spasticity Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Spasticity Treatment Product Solution and Service
Table 21. Date of Enter into Spasticity Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Spasticity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Spasticity Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Spasticity Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Spasticity Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Spasticity Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Spasticity Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Spasticity Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Spasticity Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Spasticity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Spasticity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Spasticity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Spasticity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Spasticity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Spasticity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Spasticity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Spasticity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Spasticity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Spasticity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Spasticity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Spasticity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Spasticity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Spasticity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Spasticity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Spasticity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Spasticity Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Spasticity Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Spasticity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Spasticity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Spasticity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Spasticity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Spasticity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Spasticity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Spasticity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Spasticity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Spasticity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Spasticity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Spasticity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Spasticity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Codman & Shurtleff Company Details
Table 62. Codman & Shurtleff Business Overview
Table 63. Codman & Shurtleff Spasticity Treatment Product
Table 64. Codman & Shurtleff Revenue in Spasticity Treatment Business (2016-2021) & (US$ Million)
Table 65. Codman & Shurtleff Recent Development
Table 66. Medtronic Company Details
Table 67. Medtronic Business Overview
Table 68. Medtronic Spasticity Treatment Product
Table 69. Medtronic Revenue in Spasticity Treatment Business (2016-2021) & (US$ Million)
Table 70. Medtronic Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Spasticity Treatment Product
Table 74. Sanofi Revenue in Spasticity Treatment Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. InMed Pharmaceuticals Company Details
Table 77. InMed Pharmaceuticals Business Overview
Table 78. InMed Pharmaceuticals Spasticity Treatment Product
Table 79. InMed Pharmaceuticals Revenue in Spasticity Treatment Business (2016-2021) & (US$ Million)
Table 80. InMed Pharmaceuticals Recent Development
Table 81. Ipsen Company Details
Table 82. Ipsen Business Overview
Table 83. Ipsen Spasticity Treatment Product
Table 84. Ipsen Revenue in Spasticity Treatment Business (2016-2021) & (US$ Million)
Table 85. Ipsen Recent Development
Table 86. Orient Pharma Company Details
Table 87. Orient Pharma Business Overview
Table 88. Orient Pharma Spasticity Treatment Product
Table 89. Orient Pharma Revenue in Spasticity Treatment Business (2016-2021) & (US$ Million)
Table 90. Orient Pharma Recent Development
Table 91. Taj Pharmaceuticals Company Details
Table 92. Taj Pharmaceuticals Business Overview
Table 93. Taj Pharmaceuticals Spasticity Treatment Product
Table 94. Taj Pharmaceuticals Revenue in Spasticity Treatment Business (2016-2021) & (US$ Million)
Table 95. Taj Pharmaceuticals Recent Development
Table 96. MediciNova Company Details
Table 97. MediciNova Business Overview
Table 98. MediciNova Revenue in Spasticity Treatment Business (2016-2021) & (US$ Million)
Table 99. MediciNova Recent Development
Table 100. Genentech Company Details
Table 101. Genentech Business Overview
Table 102. Genentech Spasticity Treatment Product
Table 103. Genentech Revenue in Spasticity Treatment Business (2016-2021) & (US$ Million)
Table 104. Genentech Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spasticity Treatment Market Share by Type: 2020 VS 2027
Figure 2. Physical Treatment Features
Figure 3. Medicine Treatment Features
Figure 4. Global Spasticity Treatment Market Share by Application: 2020 VS 2027
Figure 5. Children Case Studies
Figure 6. Adults Case Studies
Figure 7. Spasticity Treatment Report Years Considered
Figure 8. Global Spasticity Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Spasticity Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Spasticity Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Spasticity Treatment Market Share by Regions (2022-2027)
Figure 12. Global Spasticity Treatment Market Share by Players in 2020
Figure 13. Global Top Spasticity Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spasticity Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Spasticity Treatment Revenue in 2020
Figure 15. Global Spasticity Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Spasticity Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Spasticity Treatment Market Share by Type (2016-2027)
Figure 19. North America Spasticity Treatment Market Share by Application (2016-2027)
Figure 20. North America Spasticity Treatment Market Share by Country (2016-2027)
Figure 21. United States Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Spasticity Treatment Market Share by Type (2016-2027)
Figure 25. Europe Spasticity Treatment Market Share by Application (2016-2027)
Figure 26. Europe Spasticity Treatment Market Share by Country (2016-2027)
Figure 27. Germany Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Spasticity Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Spasticity Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Spasticity Treatment Market Share by Region (2016-2027)
Figure 37. China Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Spasticity Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Spasticity Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Spasticity Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Spasticity Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Spasticity Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Spasticity Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Spasticity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Codman & Shurtleff Revenue Growth Rate in Spasticity Treatment Business (2016-2021)
Figure 57. Medtronic Revenue Growth Rate in Spasticity Treatment Business (2016-2021)
Figure 58. Sanofi Revenue Growth Rate in Spasticity Treatment Business (2016-2021)
Figure 59. InMed Pharmaceuticals Revenue Growth Rate in Spasticity Treatment Business (2016-2021)
Figure 60. Ipsen Revenue Growth Rate in Spasticity Treatment Business (2016-2021)
Figure 61. Orient Pharma Revenue Growth Rate in Spasticity Treatment Business (2016-2021)
Figure 62. Taj Pharmaceuticals Revenue Growth Rate in Spasticity Treatment Business (2016-2021)
Figure 63. MediciNova Revenue Growth Rate in Spasticity Treatment Business (2016-2021)
Figure 64. Genentech Revenue Growth Rate in Spasticity Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年） Neuroblastoma (NB) is the most common cancer in childhood and infancy. Neuroblastoma is a cancer that starts in primitive nerve cells. It rarely occurs after age around 10 years. Neuroblastoma is sometimes caused by a gene mutation passed from the parent to the child. Market Analysis and Insights: …- 世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年） Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. Market Analysis and Insights: Global Swedish Porphyria Treatment Market The global Swedish P…
- 世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年） ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. Market Analysis and Insights: Global Acquired hemophilia A Treatment Market The global Acquired hemophilia A Treatment market size is projected to reach US$ X…
- 世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…
- 世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Treatment Market The global Adenosine Deaminase Deficiency Treat…